NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=160667&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at […]

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GSK plc ("GSK plc") (NYSE:GSK) concerning possible violations of federal securities laws. GSK issued a press release on July 17, 2025, announcing "that the US Food and Drug Administration (FDA) Oncologic Drugs

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Duolingo, Inc. ("Duolingo, Inc.") (NASDAQ:DUOL) concerning possible violations of federal securities laws. On July 28, 2025, JMP Securities lowered its price target on Duolingo stock to $450 from $475, citing concerns about

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Sable Offshore Corp. (NYSE:SOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sable-offshore-corp-lawsuit-submission-form?prid=160668&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Praxis Precision Medicines, Inc. ("Praxis Precision Medicines, Inc.") (NASDAQ:PRAX) concerning possible violations of federal securities laws. Praxis Precision Medicines, Inc. issued a press release on August 4, 2025, announcing its financial results

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Tesla, Inc. (NASDAQ:TSLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tesla-inc-lawsuit-submission-form-2?prid=160670&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

(NasdaqGM:RCKT), NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline. SO WHAT: If

RCKT DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT GlobeNewswire August 10, 2025 NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (NYSE:XIFR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/xplr-infrastructure-lp-f-k-a-nextera-energy-partners-lp-lawsuit-submission-form?prid=160673&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Confluent, Inc. ("Confluent, Inc.") (NASDAQ:CFLT) concerning possible violations of federal securities laws. Confluent issued a press release on July 30, 2025, announcing its financial results for the second quarter of 2025 and